Myocardial ischemia: current concepts and future perspectives

Area of Science:

• Cardiovascular Science
• Vascular Biology
• Pathophysiology

Background:

• Ischemic heart disease is a leading global cause of death, characterized by myocardial ischemia due to oxygen supply-demand imbalance.
• Clinical manifestations arise from coronary blood flow obstruction, including plaques, thrombosis, and vasospasm, with gender differences influenced by estrogen.
• Endothelial dysfunction and Rho-kinase pathway activation are implicated in cardiovascular diseases, highlighting them as potential therapeutic targets.

Purpose of the Study:

• To explore the mechanisms underlying myocardial ischemia and its clinical manifestations.
• To investigate the role of endothelial regulation and the Rho-kinase pathway in cardiovascular disease pathogenesis.
• To identify potential therapeutic targets for ischemic heart disease.

Main Methods:

• Review of existing literature on ischemic heart disease, coronary circulation, and endothelial function.
• Analysis of the pathophysiology of myocardial ischemia, including factors like coronary plaques, thrombosis, and vasospasm.
• Examination of the involvement of the Rho-kinase pathway and endothelial dysfunction in cardiovascular disease.

Main Results:

• Myocardial ischemia results from an imbalance between oxygen supply and demand, leading to cardiac dysfunction and potentially sudden death.
• Coronary blood flow obstruction and impaired endothelial-mediated vasodilation contribute to ischemic manifestations.
• The Rho-kinase pathway plays a role in endothelial dysfunction and vascular smooth muscle hypercontraction.

Conclusions:

• Endothelial dysfunction is a key factor in cardiovascular diseases and a significant therapeutic target.
• Activation of the Rho-kinase pathway is implicated in both endothelial dysfunction and vascular hypercontraction.
• Targeting the Rho-kinase pathway presents a promising therapeutic strategy for managing ischemic heart disease.